More than $5.5 million of CIHR funding awarded to NMD4C members to strengthen neuromuscular research capacity in Canada
Congratulations to the recipients of the Fall 2022 CIHR funded project grant competition! Seven projects were awarded (>5.5M) to NMD4C members to advance neuromuscular research in Canada: Drs. Rashmi Kothary and Cynthia Gagnon (steering committee members); Dr. Bernard Brais (investigator); Drs. Elise Duchesne (2 projects funded) and Gerald Pfeffer (working group members); and Drs. Yan Burelle, Nicolas Dumont (2 projects funded), Penney Gilbert, Luc Hébert, Mireille Khacho, Keir Menzies, Louise Moyle, and Toshifumi Yokota (members). Of note, 6/7 of the funded projects were awarded to early-career researchers (Drs. Nicolas Dumont, Elise Duchesne, Mireille Khacho, and Louise Moyle). Further information on the funding recipients can be found below.
Project Title: Extra-neuronal contribution to spinal muscular atrophy disease pathogenesis ($818,550).
Principal Investigator: Dr. Rashmi Kothary; Ottawa Hospital Research Institute
Project Title: Regulation of satellite stem cell fate by LINC complex proteins ($1,071,000).
Principal Investigator: Dr. Penney Gilbert; University of Toronto
Co-Investigators: Drs. Louise Moyle and Aaron Wheeler
Project Title: Therapeutic potential of bioactive lipids as anti-fibrotic therapy for muscle regeneration and dystrophies ($757,350).
Principal Investigator: Dr. Nicolas Dumont; Centre hospitalier universitaire Sainte-Justine (Montréal, Québec)
Project Title: Targeting defective cells to restore myogenesis and muscle function in myotonic dystrophy type 1 ($761,175).
Principal Investigators: Drs. Nicolas Dumont and Elise Duchesne; Centre hospitalier universitaire Sainte-Justine (Montréal, Québec)
Project Title: IMPACT, a supervised rehabilitation program for spastic ataxias: A rater-blinded, randomized controlled trial ($638,776).
Principal Investigators: Drs. Elise Duchesne, Mylene Aubertin, Bernard Brais, and Cynthia Gagnon; Université du Québec à Chicoutimi
Co-Investigators: Drs. Rubens da Silva, Raquel Fonseca, Luc Hébert, Gerald Pfeffer
Project Title: Mitochondrial Quality Control in Muscle Stem Cells: A Determinant of Cell Fate Decision and Tissue Repair Capacity ($692,325).
Principal Investigator: Dr. Yan Burelle; University of Ottawa
Co-Investigators: Drs. Mireille Khacho, Keir Menzies
Project Title: Neutrophil Responses in Doxorubicin-Induced Myopathy ($879,750).
Principal Investigator: Javier Clemente-Casares; University of Alberta
Co-Investigators: Gavin Oudit, Toshifumi Yokota
Read next...
NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.